CLINICAL RESEARCH: ATHEROSCLEROSIS
Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose Positron Emission Tomography Is Associated With the Metabolic Syndrome
Nobuhiro Tahara, MD, PhD*,*,
Hisashi Kai, MD, PhD*,
Sho-ichi Yamagishi, MD, PhD*,
Minori Mizoguchi, MD*,
Hiroyuki Nakaura, MD, PhD*,
Masatoshi Ishibashi, MD, PhD ,
Hayato Kaida, MD, PhD ,
Kenkichi Baba, MD ,
Naofumi Hayabuchi, MD, PhD and
Tsutomu Imaizumi, MD, PhD*
* Department of Medicine, Division of Cardio-Vascular Medicine, Kurume, Japan
Department of Radiology, Kurume University School of Medicine, Kurume, Japan.
Manuscript received August 18, 2006;
revised manuscript received September 19, 2006,
accepted November 19, 2006.
* Reprints requests and correspondence: Dr. Nobuhiro Tahara, Department of Medicine, Division of Cardio-Vascular Medicine, Kurume University School of Medicine, 67 Asahimachi, Kurume 830-0011, Japan. (Email: ntahara{at}med.kurume-u.ac.jp).
Objectives: We investigated factors for carotid artery inflammation by [18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET).
Background: Inflammation is present in some atherosclerotic plaques. The FDG-PET is capable of identifying and quantifying vascular inflammation within atherosclerotic plaques.
Methods: The FDG-PET imaging was performed in 216 consecutive patients (63 ± 9 years, men:women 147:69) for cancer screening. Vascular inflammation in carotid atherosclerosis was quantified by measuring the standardized uptake value (SUV) of FDG into the artery.
Results: Multiple stepwise regression analysis revealed significant relationships between SUV and waist circumference (p < 0.001), hypertensive medication (p < 0.001), carotid intima-media thickness (p < 0.001), high-density lipoprotein cholesterol (p < 0.01, inversely), homeostasis model assessment of insulin resistance (p < 0.05), or high sensitivity C-reactive protein (p < 0.05). Age- and gender-adjusted SUV of FDG was significantly higher (p < 0.0001) in proportion to the accumulation of the number of the components of the metabolic syndrome. Thus, the metabolic syndrome was associated with increased FDG uptake in carotid atherosclerosis.
Conclusions: Our present study may suggest that the metabolic syndrome is associated with inflammation in carotid atherosclerosis. (Detection of Plaque Inflammation by Positron Emission Tomography (PET); http://www.clinicaltrials.gov/ct/show/NCT00114504; NCT00114504
[ClinicalTrials.gov]
)
|
Abbreviations and Acronyms
| | BMI = body mass index | | BP = blood pressure | | CAD = coronary artery disease | | CT = computed tomography | | CVD = cerebrovascular disease | | FDG = [18F]-fluorodeoxyglucose | | FPG = fasting plasma glucose | | HDL = high-density lipoprotein | | HOMA-IR = homeostasis model assessment of insulin resistance | | hsCRP = high sensitivity C-reactive protein | | IMT = intima-media thickness | | IRI = immunoreactive insulin | | LDL = low-density lipoprotein | | PET = positron emission tomography | | SUV = standardized uptake value |
|
This article has been cited by other articles:

|
 |

|
 |
 
J. H.F. Rudd, F. Hyafil, and Z. A. Fayad
Inflammation Imaging in Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2009;
29(7):
1009 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Menezes, C. W. Kotze, B. F. Hutton, R. Endozo, J. C. Dickson, I. Cullum, S. W. Yusuf, P. J. Ell, and A. M. Groves
Vascular Inflammation Imaging with 18F-FDG PET/CT: When to Image?
J. Nucl. Med.,
June 1, 2009;
50(6):
854 - 857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wykrzykowska, S. Lehman, G. Williams, J. A. Parker, M. R. Palmer, S. Varkey, G. Kolodny, and R. Laham
Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation
J. Nucl. Med.,
April 1, 2009;
50(4):
563 - 568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, K. S. Myers, S. Bansilal, J. Machac, M. Woodward, V. Fuster, M. E. Farkouh, and Z. A. Fayad
Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study
Circ Cardiovasc Imaging,
March 1, 2009;
2(2):
107 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Falk, T. Thim, and I. B. Kristensen
Atherosclerotic plaque, adventitia, perivascular fat, and carotid imaging.
J. Am. Coll. Cardiol. Img.,
February 1, 2009;
2(2):
183 - 186.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lee, Y. K. On, E. J. Lee, J. Y. Choi, B.-T. Kim, and K.-H. Lee
Reversal of Vascular 18F-FDG Uptake with Plasma High-Density Lipoprotein Elevation by Atherogenic Risk Reduction
J. Nucl. Med.,
August 1, 2008;
49(8):
1277 - 1282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, K. S. Myers, S. Bansilal, J. Machac, C. A. Pinto, C. Tong, A. Rafique, R. Hargeaves, M. Farkouh, V. Fuster, et al.
Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations
J. Nucl. Med.,
June 1, 2008;
49(6):
871 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sanz, P. R. Moreno, and V. Fuster
The year in atherothrombosis.
J. Am. Coll. Cardiol.,
March 4, 2008;
51(9):
944 - 955.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Brown
Aldosterone and Vascular Inflammation
Hypertension,
February 1, 2008;
51(2):
161 - 167.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nahrendorf, H. Zhang, S. Hembrador, P. Panizzi, D. E. Sosnovik, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder
Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis
Circulation,
January 22, 2008;
117(3):
379 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. S. Dunphy, H. Schoder, and H. W. Strauss
Radionuclide Techniques for Identifying Vulnerable Plaque
J. Nucl. Med.,
November 1, 2007;
48(11):
1753 - 1755.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hartung, A. Petrov, N. Haider, S. Fujimoto, F. Blankenberg, A. Fujimoto, R. Virmani, F. D. Kolodgie, H. W. Strauss, and J. Narula
Radiolabeled Monocyte Chemotactic Protein 1 for the Detection of Inflammation in Experimental Atherosclerosis
J. Nucl. Med.,
November 1, 2007;
48(11):
1816 - 1821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tahara, H. Kai, H. Nakaura, M. Mizoguchi, M. Ishibashi, H. Kaida, K. Baba, N. Hayabuchi, and T. Imaizumi
The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose positron emission tomography
Eur. Heart J.,
September 2, 2007;
28(18):
2243 - 2248.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|